| Lung Cancer |
1 |
1 |
| Dentistry and Oral Health |
0 |
0.9 |
| Otolaryngology |
0 |
0.88 |
| Chemotherapy |
0 |
0.69 |
| Platinum |
0 |
0.63 |
| Biologic Therapy |
0 |
0.35 |
| Small Cell Lung Cancer |
0 |
0.21 |
| Diarrhea |
0 |
0.18 |
| Genomic Medicine |
0 |
0.18 |
| Antineoplastic Drug |
0 |
0.17 |
| Cancer |
0 |
0.16 |
| Targeted Cancer Therapy |
0 |
0.16 |
| Neutropenia |
0 |
0.14 |
| Eating Disorders |
0 |
0.13 |
| Lung |
0 |
0.12 |
| Nausea |
0 |
0.12 |
| Anorexia Nervosa |
0 |
0.1 |
| Epidermal Growth Factor Receptor |
0 |
0.1 |
| Fatigue |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Tobacco Cessation |
0 |
0.1 |
| Tyrosine Kinase Inhibitor |
0 |
0.1 |
| Anemia |
0 |
0.08 |
| Meta-Analysis |
0 |
0.08 |
| Patient Safety |
0 |
0.08 |
| Cough |
0 |
0.07 |
| Fever |
0 |
0.07 |
| Stomatitis |
0 |
0.07 |
| Adverse Effects |
0 |
0.06 |
| Aminotransferase |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.05 |
| Clinical Research |
0 |
0.04 |
| Tyrosine Kinase |
0 |
0.04 |
| Clinical Guidelines |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Smoking |
0 |
0.03 |
| Vascular Endothelial Growth Factor |
0 |
0.03 |
| VEGF Inhibitor |
0 |
0.03 |
| Angiogenesis Inhibitors |
0 |
0.01 |
| Humanized Monoclonal Antibody |
0 |
0.01 |
| Inpatient Care |
0 |
0.01 |
| Liver |
0 |
0.01 |
| Preventive Screening |
0 |
0.01 |
| PubMed |
0 |
0.01 |
| Statistics |
0 |
0.01 |